References
- S. G. Kapsi and J. W. Ayres, Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability, Int. J. Pharm. 229 (2001) 193-203.10.1016/S0378-5173(01)00867-5
- A. J. Aguiar, A. J. Zelmer and A. W. Kinkel, Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt, J. Pharm. Sci. 56 (1967) 1243-1252.10.1002/jps.2600561006
- P. Finholt and S. Solvang, Dissolution kinetics of drugs in human gastric juice; the role of surface tension, J. Pharm. Sci. 57 (1968) 1322-1326.10.1002/jps.2600570809
- S. L. Lin, J. Menig and L. Lachman, Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs, J. Pharm. Sci. 57 (1968) 2143-2146.10.1002/jps.2600571225
- S. Spireas and S. Sadu, Enhancement of prednisolone dissolution properties using liquisolid compacts, Int. J. Pharm. 166 (1998) 177-188.10.1016/S0378-5173(98)00046-5
- S. Spireas, S. Sadu and R. Grover, In vitro release evaluation of hydrocortisone liquisolid tablets, J. Pharm. Sci. 87 (1998) 867-872.10.1021/js970346g
- S. Spireas, T. Wang and R. Grover, Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts, Drug Dev. Ind. Pharm. 25 (1999) 163-168.10.1081/DDC-100102156
- K. Y. Yang, R. Glemza and C. I. Jarowski, Effect of amorphous silicon dioxide on drug dissolution, J. Pharm. Sci. 68 (1979) 560-565.10.1002/jps.2600680511
- C. Liao and C. I. Jarowski, Dissolution rates of corticoid solutions dispersed on silicas, J. Pharm. Sci. 73 (1984) 401-403.10.1002/jps.2600730330
- A. Nokhodchi, Y. Javadzadeh, M. R. Siahi and M. Barzegar-Jalali, The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts, J. Pharm. Pharm. Sci. 8 (2005) 18-25.
- United States Pharmacopocia 26, Natural Formulary 21, USP Convention, Rockville 2003.
- P. Costa, An alternative method to the evaluation of similarity factor in dissolution testing, Int. J. Pharm. 220 (2001) 77-83.10.1016/S0378-5173(01)00651-2
- P. Costa and J. M. S. Lobo, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133.10.1016/S0928-0987(01)00095-1
- K. A. Khan, Concept of dissolution efficiency,J. Pharm. Pharmacol. 27 (1975) 48-49.10.1111/j.2042-7158.1975.tb09378.x235616
- H. Abdou, Effect of the physicochemical properties of the drug on dissolution in Dissolution, Bioavailability and Bioequivalence (Ed. H. Abdou), Edison Mack Publishing Co., Easton, PA 1989, pp. 53-72.
- N. Kaneniwa, M. Otsuka and T. Hayashi, Physicochemical characterization of indomethacin polymorphs and transformation kinetics in ethanol, Chem. Pharm. Bull. 33 (1985) 3447-3455.10.1248/cpb.33.34474085076
- H. Imaizumi, N. Nambu and T. Nagai, Stability of several physical properties of amorphous and crystalline forms of indomethacin, Chem. Pharm. Bull. 28 (1980) 2565-2569.10.1248/cpb.28.25657460092
- L. Borka, Polymorphism of indomethacin. New modifications, their melting behavior and solubility, Acta Pharm. Suecica 11 (1974) 295-303.
- M. Otsuka, F. Kato and Y. Matsuda, Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry, Analyst 126 (2001) 1578-1582.10.1039/b103498g11592653
- M. Yoshioka, B.C. Hancock and G. Zografi, Crystallization of indomethacin from the amorphous state below and above its glass transition temperature, J. Pharm. Sci. 83 (1994) 1700-1705.10.1002/jps.26008312117891297
- H. Imaizumi, N. Nambu and T. Nagai, Stabilization of amorphous state of indomethacin by solid dispersions in polyvinylpyrolidone, Chem. Pharm. Bull. 31 (1983) 2510-2512.10.1248/cpb.31.2510